155 related articles for article (PubMed ID: 19194209)
1. Imaging evidence supports a link between essential tremor and Parkinson's disease.
Antonini A; Isaias IU
Nucl Med Commun; 2009 Feb; 30(2):93-4. PubMed ID: 19194209
[No Abstract] [Full Text] [Related]
2. Striatal dopamine transporter abnormalities in patients with essential tremor.
Isaias IU; Canesi M; Benti R; Gerundini P; Cilia R; Pezzoli G; Antonini A
Nucl Med Commun; 2008 Apr; 29(4):349-53. PubMed ID: 18317299
[TBL] [Abstract][Full Text] [Related]
3. [Imaging of dopamine transporter with Tc99m-Trodat-SPECT in movement disorders].
Kanyó B; Argyelán M; Dibó G; Szakonyi Z; Vécsei L; Fülöp F; Láncz A; Forgács P; Pávics L
Ideggyogy Sz; 2003 Jul; 56(7-8):231-40. PubMed ID: 12971118
[TBL] [Abstract][Full Text] [Related]
4. How useful is (123I) beta-CIT SPECT in the diagnosis of Parkinson's disease?
Bhidayasiri R
Rev Neurol Dis; 2006; 3(1):19-22. PubMed ID: 16596082
[TBL] [Abstract][Full Text] [Related]
5. Dopamine transporter imaging in essential tremor with and without parkinsonian features.
Waln O; Wu Y; Perlman R; Wendt J; Van AK; Jankovic J
J Neural Transm (Vienna); 2015 Nov; 122(11):1515-21. PubMed ID: 26133163
[TBL] [Abstract][Full Text] [Related]
6. Brain TRODAT-SPECT Versus MRI Morphometry in Distinguishing Early Mild Parkinson's Disease from Other Extrapyramidal Syndromes.
Hossein-Tehrani MR; Ghaedian T; Hooshmandi E; Kalhor L; Foroughi AA; Ostovan VR
J Neuroimaging; 2020 Sep; 30(5):683-689. PubMed ID: 32557946
[TBL] [Abstract][Full Text] [Related]
7. Prospective study of presynaptic dopaminergic imaging in patients with mild parkinsonism and tremor disorders: part 1. Baseline and 3-month observations.
Benamer HT; Oertel WH; Patterson J; Hadley DM; Pogarell O; Höffken H; Gerstner A; Grosset DG
Mov Disord; 2003 Sep; 18(9):977-84. PubMed ID: 14502664
[TBL] [Abstract][Full Text] [Related]
8. Two-year follow-up in 150 consecutive cases with normal dopamine transporter imaging.
Marshall VL; Patterson J; Hadley DM; Grosset KA; Grosset DG
Nucl Med Commun; 2006 Dec; 27(12):933-7. PubMed ID: 17088677
[TBL] [Abstract][Full Text] [Related]
9. Role of dopamine transporter imaging in the diagnosis of atypical tremor disorders.
Marshall V; Grosset DG
Mov Disord; 2003 Oct; 18 Suppl 7():S22-7. PubMed ID: 14531042
[TBL] [Abstract][Full Text] [Related]
10. Molecular imaging studies in Parkinson disease: reducing diagnostic uncertainty.
Felicio AC; Shih MC; Godeiro-Junior C; Andrade LA; Bressan RA; Ferraz HB
Neurologist; 2009 Jan; 15(1):6-16. PubMed ID: 19131852
[TBL] [Abstract][Full Text] [Related]
11. Patients with Parkinson's disease and scans with (predominant) ipsilateral dopaminergic deficit.
Erro R; Barone P; Vicidomini C; Picillo M; Pappatà S
J Neurol; 2013 Sep; 260(9):2405-6. PubMed ID: 23918004
[No Abstract] [Full Text] [Related]
12. Role of dopamine transporter imaging in routine clinical practice.
Marshall V; Grosset D
Mov Disord; 2003 Dec; 18(12):1415-23. PubMed ID: 14673877
[TBL] [Abstract][Full Text] [Related]
13. The relationship between essential tremor and Parkinson's disease.
Thenganatt MA; Jankovic J
Parkinsonism Relat Disord; 2016 Jan; 22 Suppl 1():S162-5. PubMed ID: 26522219
[TBL] [Abstract][Full Text] [Related]
14. [(11)C]d-threo-methylphenidate PET in patients with Parkinson's disease and essential tremor.
Breit S; Reimold M; Reischl G; Klockgether T; Wüllner U
J Neural Transm (Vienna); 2006 Feb; 113(2):187-93. PubMed ID: 15959851
[TBL] [Abstract][Full Text] [Related]
15. Clinical impact of diagnostic SPET investigations with a dopamine re-uptake ligand.
Løkkegaard A; Werdelin LM; Friberg L
Eur J Nucl Med Mol Imaging; 2002 Dec; 29(12):1623-9. PubMed ID: 12458397
[TBL] [Abstract][Full Text] [Related]
16. Can SPET imaging of dopamine uptake sites replace PET imaging in Parkinson's disease? For.
Tatsch K
Eur J Nucl Med Mol Imaging; 2002 May; 29(5):711-4. PubMed ID: 11976813
[No Abstract] [Full Text] [Related]
17. Validation of a standardized normalization template for statistical parametric mapping analysis of 123I-FP-CIT images.
Kas A; Payoux P; Habert MO; Malek Z; Cointepas Y; El Fakhri G; Chaumet-Riffaud P; Itti E; Remy P
J Nucl Med; 2007 Sep; 48(9):1459-67. PubMed ID: 17704252
[TBL] [Abstract][Full Text] [Related]
18. Dual-tracer dopamine transporter and perfusion SPECT in differential diagnosis of parkinsonism using template-based discriminant analysis.
Van Laere K; Casteels C; De Ceuninck L; Vanbilloen B; Maes A; Mortelmans L; Vandenberghe W; Verbruggen A; Dom R
J Nucl Med; 2006 Mar; 47(3):384-92. PubMed ID: 16513606
[TBL] [Abstract][Full Text] [Related]
19. Clinical impact of correlative [123I]-FP-CIT brain imaging and neurological findings in suspect Parkinson's disease.
Covelli EM; Brunetti A; Di Lauro A; Sullo P; Mazzarella G; Tedeschi E; Belfiore G
Radiol Med; 2004 Oct; 108(4):417-25. PubMed ID: 15525895
[TBL] [Abstract][Full Text] [Related]
20. Do non-motor symptoms in Parkinson's disease differ from essential tremor before initial diagnosis? A clinical and scintigraphic study.
Giorelli M; Bagnoli J; Consiglio L; Lopane M; Zimatore GB; Zizza D; Difazio P
Parkinsonism Relat Disord; 2014 Jan; 20(1):17-21. PubMed ID: 24080307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
